Larvol Delta - A-Study-to-Evaluate-Concurrent-VRPHER2-Vaccination-and-Pembrolizumab-for-Patients-With-Breast-Cancer

AVX901 - AlphaVax

Keytruda (pembrolizumab) - Merck (MSD)

http://clinicaltrials.gov/ct2/show/NCT03632941

Dec 20, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next